SEC Form D · Amendment · filed October 11, 2022
Elysium Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (18)
Bob G. Rappaport · Akron, OHDirectorKathy G. Laporte · Akron, OHDirectorCarey G. Ng · Akron, OHDirectorAlex G. Sturmer · Akron, OHExec · DirectorJames G. Hackworth · Akron, OHDirectorThomas G. Jenkins · Akron, OHDirectorRichard A. Donato · Allison Park, PADirectorShameet M. Luhar · Columbia, MDExec · DirectorGanesh Rengaswamy · Bangalore, K7DirectorMark D. Feldman · Gibsonia, PADirectorEric C. Haufler · Pittsburgh, PADirectorRobert C. Erwin · Pittsburgh, PADirectorA. E. Barbera · Boulder, COExec · DirectorKarl Nicholls · Boulder, CODirectorMichael Kinley · Bedford, Nova Scotia, CanadaDirectorKevin Thieneman · Hilton Head Island, Nova Scotia, CanadaDirectorLara A. Riachy · Luxembourg, LuxembourgDirectorFrancois Bourgon · Luxembourg, LuxembourgDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗